Loading clinical trials...
Loading clinical trials...
A Pivotal Pharmacokinetic Study Investigating the Extent of Absorptions of Paracetamol and Caffeine for Two Different Paracetomol Formulations Containing Caffeine
This PK study is designed to show bioequivalence between the study treatments.
Age
18 - 55 years
Sex
ALL
Healthy Volunteers
Yes
MDS Pharma Services ARIZONA
Phoenix, Arizona, United States
Start Date
July 1, 2009
Primary Completion Date
August 1, 2009
Completion Date
August 1, 2009
Last Updated
November 24, 2014
30
ACTUAL participants
Experimental paracetamol
DRUG
Paracetamol marketed formulation
DRUG
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions